Kostyk, Sandra K.
University of Iowa · The Ohio State University
4 papers on CoChatORCID 0000-0002-3371-753X
Most cited papers
- Verified
AAV2-GAD gene therapy for advanced Parkinson’s disease: a double-blind, sham-surgery controlled, randomised trial
LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Thomas, K., Sarkar, A., Siddiqui, M. S., et al. (2011) · The Lancet Neurology
Deep Brain Stimulation and Movement DisordersParkinson's Disease Mechanisms and Treatments
Cited by 681
- Verified
Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson’s disease
Niethammer, M., Tang, C. C., LeWitt, P. A., Rezai, A. R., Leehey, M. A., Ojemann, S. G., Flaherty, A. W., Eskandar, E. N., Kostyk, S. K., Sarkar, A., et al. (2017) · JCI Insight
Deep Brain Stimulation and Movement DisordersParkinson's Disease Mechanisms and Treatments
Cited by 124
- Verified
Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial
Feigin, A., Evans, E. E., Fisher, T. L., Leonard, J. E., Smith, E. S., Reader, A., Mishra, V., Manber, R., Walters, K. A., Kowarski, L., et al. (2022) · Nature Medicine
Genetic Neurodegenerative DiseasesParkinson's Disease Mechanisms and Treatments
Cited by 67
- Verified
Age of onset and behavioral manifestations in Huntington's disease: An Enroll‐HD cohort analysis
Ranganathan, M., Kostyk, S. K., Allain, D. C., Race, J. A., & Daley, A. M. (2021) · Clinical Genetics
Genetic Neurodegenerative DiseasesObsessive-Compulsive Spectrum Disorders
Cited by 20
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free